The IRE1/XBP1 route was described to be crucial for differentiation and survival of plasma cells [25, 26], thus, we postulated that PRIMA-1 may be exerting its anti-myeloma role by inhibiting the pro-survival effects of IRE1/XBP1. Here, ERN1 is linked to plasma cell myeloma.